Indong, Crystelle Ambher U.
HRN: 28-03-23 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2025
CEFUROXIME 750MG (VIAL)
10/28/2025
11/03/2025
IV
450mg
Q8h
PCAP C
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes